🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Our new findings on cancer care quality for low-income Medicare patients, out last week in Journal of Clinical Oncology! 🧵 to follow 1/ x.com/JCO_ASCO/statu…

Calling all oncology pharmacists! Join our study on AI in #OncoPharm with a quick 5-min survey. What excites or concerns you? How could AI transform your practice? Open until 11/22. 💊🤖💡 tinyurl.com/aioncopharm

We need honest conversations about the recent anti-DEI movement which inaccurately frames itself as a push for meritocracy. This is not it.

Will be leaving this platform soon and transitioning to:

We presented NINR K23 supported findings of system factors affecting med adherence from the perspective of patients with #multiplemyeloma

#UNCPharmacy has partnered with Addis Ababa University and co-director of the UNC-Ethiopia Alliance Benyam Muluneh, PharmD, BCOP, FHOPA to create a Pharmacy Administration and Leadership Short Course in Ethiopia! Learn more: hubs.li/Q02Zp_Yf0

One more time: Women aren't too emotional to lead. Data: When men are anxious and stressed, they're more likely to be rude, hostile, and abusive. Women show respect regardless of their feelings. The test of emotional intelligence is not how you feel. It's how you respond.

Crockett: It was my ancestors that built the White House. If we have been good enough to build this country, we are good enough to serve in other ways. Stop trying to act as if only white men are the ones that are capable because you’re sitting with 3 very capable black women

Jeffries: Diversity, equity and inclusion are American values. Perhaps I can explain. The motto of the United States of America is e pluribus unum. Out of many, one. That’s diversity. The 14th Amendment to the United States Constitution—one of the most influential important

HOPA's OCC, with the participation of ASCO Quality Training Programs, has developed practice-based tools to aid in developing and improving initiatives and the care of patients receiving oral anticancer agents (OAAs). Read the full article Journal of Clinical Oncology: bit.ly/40YzPiV

During these times, scientists cannot be silent about the fallout of ignoring health inequities. We must sustain a commitment to health equity. Thank you Contagion for providing a forum for me to discuss the impacts of health equity on AMR.

Important real world study published by the Penn Medicine Leukemia Group showing improved OS in older adults with AML in the Venetoclax era that was most significantly seen in non-Hispanic black pts compared to other ethnicities. Dr. Catherine Lai Andrew Matthews Keith W Pratz MD

HOPA's OCC, with the participation of ASCO Quality Training Programs, has developed practice-based tools to aid in developing and improving initiatives and the care of patients receiving oral anticancer agents (OAAs). Read the full article Journal of Clinical Oncology: bit.ly/40YzPiV

Cc. Department of Government Efficiency

There's a lot of misinformation out there about WHO's funding, so let's clear things up! Stay informed, stay curious, and stay with facts.

Thanks Sally for your support

Multicenter retrospective evaluation of treatment for high risk acute promyelocytic leukemia: Real-World Outcomes from the HERO consortium First comparison between APML4 and ATRA+ATO+GO in high risk #APL doi.org/10.1002/ajh.27… #AML #LeuSM

What is the best treatment for high-risk APL? Are GO-based regimens better than APML4-style? 🤔 Check out our FIRST major multi-center hematology PharmD pub and find out! 👀 #leusm #apl #HEROconsortium onlinelibrary.wiley.com/doi/10.1002/aj…

Maintenance Therapy in AML: A Trailblazing Slam Dunk, or a Flagrant Fowl. Always a pleasure to hear Anthony Perissinotti Bernie Marini. What a lively and engaging debate! #HOPA2025

Multicenter retrospective evaluation of treatment for high risk acute promyelocytic #leukemia: Comparison of the APML4 and ATRA+ATO+GO in high risk #APL conducted by the HERO Consortium Free access: doi.org/10.1002/ajh.27… #LeuSM Bernie Marini #HemOnc